Perceptions of artificial intelligence in healthcare: findings from a qualitative survey study among actors in France
Top Cited Papers
Open Access
- 9 January 2020
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 18 (1) , 1-13
Abstract
Background: Artificial intelligence (AI), with its seemingly limitless power, holds the promise to truly revolutionize patient healthcare. However, the discourse carried out in public does not always correlate with the actual impact. Thus, we aimed to obtain both an overview of how French health professionals perceive the arrival of AI in daily practice and the perception of the other actors involved in AI to have an overall understanding of this issue.Methods: Forty French stakeholders with diverse backgrounds were interviewed in Paris between October 2017 and June 2018 and their contributions analyzed using the grounded theory method (GTM).Results: The interviews showed that the various actors involved all see AI as a myth to be debunked. However, their views differed. French healthcare professionals, who are strategically placed in the adoption of AI tools, were focused on providing the best and safest care for their patients. Contrary to popular belief, they are not always seeing the use of these tools in their practice. For healthcare industrial partners, AI is a true breakthrough but legal difficulties to access individual health data could hamper its development. Institutional players are aware that they will have to play a significant role concerning the regulation of the use of these tools. From an external point of view, individuals without a conflict of interest have significant concerns about the sustainability of the balance between health, social justice, and freedom. Health researchers specialized in AI have a more pragmatic point of view and hope for a better transition from research to practice.Conclusion: Although some hyperbole has taken over the discourse on AI in healthcare, diverse opinions and points of view have emerged among French stakeholders. The development of AI tools in healthcare will be satisfactory for everyone only by initiating a collaborative effort between all those involved. It is thus time to also consider the opinion of patients and, together, address the remaining questions, such as that of responsibility.Keywords
Funding Information
- CARPEM program (INCA-DGOS-INSERM_12561)
This publication has 41 references indexed in Scilit:
- Artificial Intelligence in Medical Practice: The Question to the Answer?The American Journal of Medicine, 2018
- Smartphone apps for skin cancer diagnosis: Implications for patients and practitionersAustralasian Journal of Dermatology, 2018
- When Machines Think: Radiology’s Next FrontierRadiology, 2017
- Dermatologist-level classification of skin cancer with deep neural networksNature, 2017
- Adapting to Artificial IntelligenceJAMA, 2016
- Relative Values: Perspectives on a Neuroimaging Technology From Above and Within the Ethical LandscapeJournal of Bioethical Inquiry, 2016
- Point-of-care testing in UK primary care: a survey to establish clinical needsFamily Practice, 2016
- Translational research—the need of a new bioethics approachJournal of Translational Medicine, 2016
- Using Grounded Theory Method to Capture and Analyze Health Care ExperiencesHealth Services Research, 2014
- Translational research: Crossing the valley of deathNature, 2008